The Nifty Pharma index covers India’s drug makers, from domestic-formulation players to US-generics exporters. Ranking it by relative strength shows which pharma names are leading as the sector rotates.
Trendvue ranks every Nifty Pharma constituent by O’Neil RS Rating (1–99) alongside its 1-month, 3-month and 1-year return, refreshed after every NSE close. The table reads as a live leaderboard of the index’s strongest and weakest names, so you can see where relative strength is building — and where it is fading — before it shows up in the headline index move.
As of 2026-08-03 · 20 stocks
| Symbol | Company | RS Rating | 1M % | 3M % | 1Y % | % from 52W High |
|---|---|---|---|---|---|---|
| LAURUSLABS | LAURUS LABS LIMITED | 94 | +17.42% | +55.27% | +116.50% | -1.48% |
| GLAND | GLAND PHARMA LIMITED | 88 | +4.75% | +42.07% | +27.81% | -0.26% |
| SAILIFE | SAI LIFE SCIENCES LIMITED | 87 | +6.06% | +23.27% | +61.53% | -1.23% |
| WOCKPHARMA | WOCKHARDT LIMITED | 84 | +4.64% | +42.35% | +19.23% | -16.26% |
| DIVISLAB | DIVI S LABORATORIES LTD | 82 | +23.87% | +26.45% | +26.47% | -2.50% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 82 | +5.42% | +18.23% | +42.81% | -4.25% |
| AJANTPHARM | AJANTA PHARMA LIMITED | 81 | +5.61% | +21.11% | +25.62% | -2.39% |
| AUROPHARMA | AUROBINDO PHARMA LTD | 79 | -4.57% | +12.38% | +38.80% | -5.52% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 77 | -2.42% | +23.35% | +14.60% | -5.80% |
| PPLPHARMA | PIRAMAL PHARMA LIMITED | 74 | +13.36% | +24.43% | -1.83% | -5.24% |
| IPCALAB | IPCA LABORATORIES LTD | 73 | -2.95% | +12.84% | +12.05% | -11.23% |
| BIOCON | BIOCON LIMITED. | 71 | -0.20% | +18.12% | +7.13% | -4.74% |
| LUPIN | LUPIN LIMITED | 70 | -4.18% | +1.00% | +22.20% | -6.21% |
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 70 | +2.10% | +6.65% | +14.94% | -4.99% |
| ALKEM | ALKEM LABORATORIES LTD. | 68 | +2.20% | +6.05% | +13.73% | -4.19% |
| CIPLA | CIPLA LTD | 61 | +0.31% | +9.57% | -1.69% | -12.57% |
| MANKIND | MANKIND PHARMA LIMITED | 59 | -1.97% | +9.78% | -4.28% | -7.30% |
| GLENMARK | GLENMARK PHARMACEUTICALS | 56 | +0.19% | -7.46% | +3.31% | -10.46% |
| ABBOTINDIA | ABBOTT INDIA LIMITED | 51 | +7.61% | +9.64% | -19.42% | -21.08% |
| DRREDDY | DR. REDDY S LABORATORIES | 44 | -14.86% | -9.11% | -7.55% | -17.32% |
A sector index of pharmaceutical companies listed on the NSE.
A relative-strength score from 1 to 99 that ranks a stock’s trailing 12-month price performance against the whole market — 99 is the strongest, 1 the weakest. It follows the O’Neil methodology.
After every NSE close, on settled end-of-day data.